Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Peritoneal Dialysis | Study protocol

Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes (DOMESTICO): rationale and design

Authors: A. van Eck van der Sluijs, A. A. Bonenkamp, F. W. Dekker, A. C. Abrahams, B. C. van Jaarsveld, on behalf of the DOMESTICO study group

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

More than 6200 End Stage Renal Disease patients in the Netherlands are dependent on dialysis, either performed at home or in a dialysis centre. Visiting a dialysis centre three times a week is considered a large burden by many patients. However, recent data regarding the effects of dialysis at home on quality of life, clinical outcomes, and costs compared with in-centre haemodialysis are lacking.

Methods

The Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes (DOMESTICO) is a nationwide, prospective, observational cohort study that will include adult patients starting with a form of dialysis. Health-related quality of life, as the primary outcome, clinical outcomes and costs, as secondary outcomes, will be measured every 3–6 months in patients on home dialysis, and compared with a control group consisting of in-centre haemodialysis patients. During a 3-year period 800 home dialysis patients (600 peritoneal dialysis and 200 home haemodialysis patients) and a comparison group of 800 in-centre haemodialysis patients will be included from 53 Dutch dialysis centres (covering 96% of Dutch centres) and 1 Belgian dialysis centre (covering 4% of Flemish centres).

Discussion

DOMESTICO will prospectively investigate the effect of home dialysis therapies on health-related quality of life, clinical outcomes and costs, in comparison with in-centre haemodialysis. The findings of this study are expected to ameliorate the shared decision-making process and give more guidance to healthcare professionals, in particular to assess which type of patients may benefit most from home dialysis.

Trial registration

The DOMESTICO study is registered with the National Trial Register on (number: NL6519, date of registration: 22 August 2017) and the Central Committee on Research Involving Human Subjects (CCMO) (number: NL63277.029.17).
Appendix
Available only for authorised users
Literature
2.
go back to reference Hemke AC, Dekker FW, Bos WJW, et al. Oorzaken voor verminderd aandeel peritoneale dialyse als nierfunctievervangende behandeling in Nederland. Ned Tijdschr Geneeskd. 2012;156:1–8. Hemke AC, Dekker FW, Bos WJW, et al. Oorzaken voor verminderd aandeel peritoneale dialyse als nierfunctievervangende behandeling in Nederland. Ned Tijdschr Geneeskd. 2012;156:1–8.
4.
go back to reference Gorodetskaya I, Zenios S, McCulloch CE, et al. Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int. 2005;68:2801–8.CrossRef Gorodetskaya I, Zenios S, McCulloch CE, et al. Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int. 2005;68:2801–8.CrossRef
5.
go back to reference van de Luijtgaarden MWM, Jager KJ, Segelmark M, et al. Trends in dialysis modality choice and related patient survival in the ERA-EDTA registry over a 20-year period. Nephrol Dial Transplant. 2016;31:120–8.CrossRef van de Luijtgaarden MWM, Jager KJ, Segelmark M, et al. Trends in dialysis modality choice and related patient survival in the ERA-EDTA registry over a 20-year period. Nephrol Dial Transplant. 2016;31:120–8.CrossRef
6.
go back to reference Kramer A, Pippias M, Noordzij M, et al. The European renal association - European Dialysis and transplant association (ERA-EDTA) registry annual report 2015: a summary. Clin Kidney J. 2018;11(1):108–22.CrossRef Kramer A, Pippias M, Noordzij M, et al. The European renal association - European Dialysis and transplant association (ERA-EDTA) registry annual report 2015: a summary. Clin Kidney J. 2018;11(1):108–22.CrossRef
8.
go back to reference Ageborg M, Allenius BL, Cederfjall C. Quality of life, self-care ability, and sense of coherence in hemodialysis patients: a comparative study. Hemodial Int. 2005;9:S8–14.CrossRef Ageborg M, Allenius BL, Cederfjall C. Quality of life, self-care ability, and sense of coherence in hemodialysis patients: a comparative study. Hemodial Int. 2005;9:S8–14.CrossRef
9.
go back to reference Al Wakeel J, Al Harbi A, Bayoumi M, et al. Quality of life in hemodialysis and peritoneal dialysis patients in Saudi Arabia. Ann Saudi Med. 2012;32(6):570–4.CrossRef Al Wakeel J, Al Harbi A, Bayoumi M, et al. Quality of life in hemodialysis and peritoneal dialysis patients in Saudi Arabia. Ann Saudi Med. 2012;32(6):570–4.CrossRef
10.
go back to reference Atapour A, Nasr S, Boroujeni AM, et al. A comparison of the quality of life of the patients undergoing hemodialysis versus peritoneal dialysis and its correlation to the quality of dialysis. Saudi J Kidney Dis Transpl. 2016;27(2):270–80.CrossRef Atapour A, Nasr S, Boroujeni AM, et al. A comparison of the quality of life of the patients undergoing hemodialysis versus peritoneal dialysis and its correlation to the quality of dialysis. Saudi J Kidney Dis Transpl. 2016;27(2):270–80.CrossRef
11.
go back to reference Barata NE. Dyadic relationship and quality of life patients with chronic kidney disease. J Bras Nefrol. 2015;37(3):315–22.CrossRef Barata NE. Dyadic relationship and quality of life patients with chronic kidney disease. J Bras Nefrol. 2015;37(3):315–22.CrossRef
12.
go back to reference Basok EK, Atsu N, Rifaioglu MM, et al. Assessment of female sexual function and quality of life in predialysis, peritoneal dialysis, hemodialysis, and renal transplant patients. Int Urol Nephrol. 2009;41(3):473–81.CrossRef Basok EK, Atsu N, Rifaioglu MM, et al. Assessment of female sexual function and quality of life in predialysis, peritoneal dialysis, hemodialysis, and renal transplant patients. Int Urol Nephrol. 2009;41(3):473–81.CrossRef
13.
go back to reference Baykan H, Yargic I. Depression, anxiety disorders, quality of life and stress coping strategies in hemodialysis and continuous ambulatory peritoneal dialysis patients. Klinik Psikofarmakoloji Bulteni. 2012;22(2):167–76.CrossRef Baykan H, Yargic I. Depression, anxiety disorders, quality of life and stress coping strategies in hemodialysis and continuous ambulatory peritoneal dialysis patients. Klinik Psikofarmakoloji Bulteni. 2012;22(2):167–76.CrossRef
14.
go back to reference Borowiak E, Braksator E, Nowicki M, et al. Quality of life of chronic hemodialysis and peritoneal dialysis patients. Clin Exp Med Lett. 2009;50(1):37–42. Borowiak E, Braksator E, Nowicki M, et al. Quality of life of chronic hemodialysis and peritoneal dialysis patients. Clin Exp Med Lett. 2009;50(1):37–42.
15.
go back to reference Brown EA, Johansson L, Farrington K, et al. Broadening options for long-term Dialysis in the elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol Dial Transplant. 2010;25(11):3755–63.CrossRef Brown EA, Johansson L, Farrington K, et al. Broadening options for long-term Dialysis in the elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol Dial Transplant. 2010;25(11):3755–63.CrossRef
16.
go back to reference Chen JY, Wan EYF, Choi EPH, et al. The health-related quality of life of Chinese patients on hemodialysis and peritoneal Dialysis. Patient. 2017:1–10. Chen JY, Wan EYF, Choi EPH, et al. The health-related quality of life of Chinese patients on hemodialysis and peritoneal Dialysis. Patient. 2017:1–10.
17.
go back to reference Czyzewski L, Sanko-Resmer J, Wyzgal J, et al. Assessment of health-related quality of life of patients after kidney transplantation in comparison with hemodialysis and peritoneal dialysis. Ann Transplant. 2014;19:576–85.CrossRef Czyzewski L, Sanko-Resmer J, Wyzgal J, et al. Assessment of health-related quality of life of patients after kidney transplantation in comparison with hemodialysis and peritoneal dialysis. Ann Transplant. 2014;19:576–85.CrossRef
18.
go back to reference Fructuoso M, Castro R, Oliveira L, et al. Quality of life in chronic kidney disease. Nefrologia. 2011;31(1):91–6.PubMed Fructuoso M, Castro R, Oliveira L, et al. Quality of life in chronic kidney disease. Nefrologia. 2011;31(1):91–6.PubMed
19.
go back to reference Goncalves FA, Dalosso IF, Borba JM, et al. Quality of life in chronic renal patients on hemodialysis or peritoneal dialysis: a comparative study in a referral service of Curitiba - PR. Jornal brasileiro de nefrologia. 2015;37(4):467–74.CrossRef Goncalves FA, Dalosso IF, Borba JM, et al. Quality of life in chronic renal patients on hemodialysis or peritoneal dialysis: a comparative study in a referral service of Curitiba - PR. Jornal brasileiro de nefrologia. 2015;37(4):467–74.CrossRef
20.
go back to reference Ibrahim N, Chiew-Tong NK, Desa A. Symptoms and health-related quality of life in patients with heamodialysis and continuous ambulatory peritoneal dialysis. Res J Med Sci. 2011;5(5):252–6. Ibrahim N, Chiew-Tong NK, Desa A. Symptoms and health-related quality of life in patients with heamodialysis and continuous ambulatory peritoneal dialysis. Res J Med Sci. 2011;5(5):252–6.
21.
go back to reference Ikonomou M, Skapinakis P, Balafa O, et al. The impact of socioeconomic factors on quality of life of patients with chronic kidney disease in Greece. J Ren Care. 2015;41(4):239–46.CrossRef Ikonomou M, Skapinakis P, Balafa O, et al. The impact of socioeconomic factors on quality of life of patients with chronic kidney disease in Greece. J Ren Care. 2015;41(4):239–46.CrossRef
22.
go back to reference Kim JY, Kim B, Park KS, et al. Health-related quality of life with KDQOL-36 and its association with self-efficacy and treatment satisfaction in Korean dialysis patients. Qual Life Res. 2013;22(4):753–8.CrossRef Kim JY, Kim B, Park KS, et al. Health-related quality of life with KDQOL-36 and its association with self-efficacy and treatment satisfaction in Korean dialysis patients. Qual Life Res. 2013;22(4):753–8.CrossRef
23.
go back to reference Kontodimopoulos N, Pappa E, Niakas D. Gender- and age-related benefit of renal replacement therapy on health-related quality of life. Scand J Caring Sci. 2009;23(4):721–9.CrossRef Kontodimopoulos N, Pappa E, Niakas D. Gender- and age-related benefit of renal replacement therapy on health-related quality of life. Scand J Caring Sci. 2009;23(4):721–9.CrossRef
24.
go back to reference Liu WJ, Musa R, Chew TF, et al. Quality of life in dialysis: a Malaysian perspective. Hemodial Int. 2014;18(2):495–506.CrossRef Liu WJ, Musa R, Chew TF, et al. Quality of life in dialysis: a Malaysian perspective. Hemodial Int. 2014;18(2):495–506.CrossRef
25.
go back to reference Maglakelidze N, Pantsulaia T, Tchokhonelidze I, et al. Assessment of health-related quality of life in renal transplant recipients and dialysis patients. Transplant Proc. 2011;43(1):376–9.CrossRef Maglakelidze N, Pantsulaia T, Tchokhonelidze I, et al. Assessment of health-related quality of life in renal transplant recipients and dialysis patients. Transplant Proc. 2011;43(1):376–9.CrossRef
26.
go back to reference Nakayama M, Ishida M, Ogihara M, et al. Social functioning and socioeconomic changes after introduction of regular dialysis treatment and impact of dialysis modality: a multi-Centre survey of Japanese patients. Nephrology (Carlton). 2015;20(8):523–30.CrossRef Nakayama M, Ishida M, Ogihara M, et al. Social functioning and socioeconomic changes after introduction of regular dialysis treatment and impact of dialysis modality: a multi-Centre survey of Japanese patients. Nephrology (Carlton). 2015;20(8):523–30.CrossRef
27.
go back to reference Okpechi IG, Nthite T, Swanepoel CR. Health-related quality of life in patients on hemodialysis and peritoneal dialysis. Saudi J Kidney Dis Transpl. 2013;24(3):519–26.CrossRef Okpechi IG, Nthite T, Swanepoel CR. Health-related quality of life in patients on hemodialysis and peritoneal dialysis. Saudi J Kidney Dis Transpl. 2013;24(3):519–26.CrossRef
28.
go back to reference Ören B, Enc N. Quality of life in chronic haemodialysis and peritoneal dialysis patients in Turkey and related factors. Int J Nurs Pract. 2013;19(6):547–56.CrossRef Ören B, Enc N. Quality of life in chronic haemodialysis and peritoneal dialysis patients in Turkey and related factors. Int J Nurs Pract. 2013;19(6):547–56.CrossRef
29.
go back to reference Ramos EC, Santos I, Zanini R, et al. Quality of life of chronic renal patients in peritoneal dialysis and hemodialysis. Jornal brasileiro de nefrologia. 2015;37(3):297–305.CrossRef Ramos EC, Santos I, Zanini R, et al. Quality of life of chronic renal patients in peritoneal dialysis and hemodialysis. Jornal brasileiro de nefrologia. 2015;37(3):297–305.CrossRef
30.
go back to reference Tannor EK, Archer E, Kapembwa K, et al. Quality of life in patients on chronic dialysis in South Africa: a comparative mixed methods study. BMC Nephrol. 2017;18(1):4.CrossRef Tannor EK, Archer E, Kapembwa K, et al. Quality of life in patients on chronic dialysis in South Africa: a comparative mixed methods study. BMC Nephrol. 2017;18(1):4.CrossRef
31.
go back to reference Theofilou P. Quality of life in patients undergoing hemodialysis or peritoneal dialysis treatment. J Clin Med Res. 2011;3(3):132–8.PubMedPubMedCentral Theofilou P. Quality of life in patients undergoing hemodialysis or peritoneal dialysis treatment. J Clin Med Res. 2011;3(3):132–8.PubMedPubMedCentral
32.
go back to reference Turkmen K, Yazici R, Solak Y, et al. Health-related quality of life, sleep quality, and depression in peritoneal dialysis and hemodialysis patients. Hemodial Int. 2012;16(2):198–206.CrossRef Turkmen K, Yazici R, Solak Y, et al. Health-related quality of life, sleep quality, and depression in peritoneal dialysis and hemodialysis patients. Hemodial Int. 2012;16(2):198–206.CrossRef
33.
go back to reference Watanabe Y, Ohno Y, Inoue T, et al. Home hemodialysis and conventional in-center hemodialysis in Japan: a comparison of health-related quality of life. Hemodial Int. 2014;18(Suppl 1):S32–8.CrossRef Watanabe Y, Ohno Y, Inoue T, et al. Home hemodialysis and conventional in-center hemodialysis in Japan: a comparison of health-related quality of life. Hemodial Int. 2014;18(Suppl 1):S32–8.CrossRef
34.
go back to reference Wright LS, Wilson L. Quality of life and self-efficacy in three Dialysis modalities: Incenter hemodialysis, home hemodialysis, and home peritoneal Dialysis. Nephrol Nurs J. 2015;42(5):463–76.PubMed Wright LS, Wilson L. Quality of life and self-efficacy in three Dialysis modalities: Incenter hemodialysis, home hemodialysis, and home peritoneal Dialysis. Nephrol Nurs J. 2015;42(5):463–76.PubMed
35.
go back to reference Wu F, Cui L, Gao X, et al. Quality of life in peritoneal and hemodialysis patients in China. Ren Fail. 2013;35(4):456–9.CrossRef Wu F, Cui L, Gao X, et al. Quality of life in peritoneal and hemodialysis patients in China. Ren Fail. 2013;35(4):456–9.CrossRef
36.
go back to reference Yang F, Griva K, Lau T, et al. Health-related quality of life of Asian patients with end-stage renal disease (ESRD) in Singapore. Qual Life Res. 2015;24(9):2163–71.CrossRef Yang F, Griva K, Lau T, et al. Health-related quality of life of Asian patients with end-stage renal disease (ESRD) in Singapore. Qual Life Res. 2015;24(9):2163–71.CrossRef
37.
go back to reference Ying SC, Krishnan M. Interpretation of quality of life outcomes amongst end stage renal disease patients in selected hospitals of Malaysia. Int J Pharm Sci Res. 2014;5(1):60–9. Ying SC, Krishnan M. Interpretation of quality of life outcomes amongst end stage renal disease patients in selected hospitals of Malaysia. Int J Pharm Sci Res. 2014;5(1):60–9.
38.
go back to reference Yongsiri S, Thammakumpee J, Prongnamchai S, et al. The association between bioimpedance analysis and quality of life in pre-dialysis stage 5 chronic kidney disease, hemodialysis and peritoneal dialysis patients. J Med Assoc Thail. 2014;97(3):293–9. Yongsiri S, Thammakumpee J, Prongnamchai S, et al. The association between bioimpedance analysis and quality of life in pre-dialysis stage 5 chronic kidney disease, hemodialysis and peritoneal dialysis patients. J Med Assoc Thail. 2014;97(3):293–9.
39.
go back to reference Ware JE, Kosinski MM, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.CrossRef Ware JE, Kosinski MM, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.CrossRef
40.
go back to reference Weisbord SD, Fried LF, Arnold RM, et al. Development of a symptom assessment instrument for chronic hemodialysis patients: the Dialysis symptom index. J Pain Symptom Manag. 2004;27(3):226–40.CrossRef Weisbord SD, Fried LF, Arnold RM, et al. Development of a symptom assessment instrument for chronic hemodialysis patients: the Dialysis symptom index. J Pain Symptom Manag. 2004;27(3):226–40.CrossRef
41.
go back to reference Van der Willik EM, Leegte M, van Ittersum FJ, Prantl K, Bart HAJ, Dekker FW, Hemmelder MH. First Dutch registry of patient-reported outcome measures (PROMS) has a low response in dialysis patients [abstract]. Nephrology Dialysis Transplantation. 2018;33(Suppl 1):i262.CrossRef Van der Willik EM, Leegte M, van Ittersum FJ, Prantl K, Bart HAJ, Dekker FW, Hemmelder MH. First Dutch registry of patient-reported outcome measures (PROMS) has a low response in dialysis patients [abstract]. Nephrology Dialysis Transplantation. 2018;33(Suppl 1):i262.CrossRef
42.
go back to reference Van der Willik EM, Meuleman Y, Prantl K, van Rijn G, Bos WJW, van Ittersum FJ, Bart HAJ, Hemmelder MH, Dekker FW. Patient-reported outcome measures: selection of a valid questionnaire for routine symptom assessment in patients with advanced chronic kidney disease – a four-phase mixed methods study. BMC Nephrology. 2019. Accepted. https://doi.org/10.1186/s12882-019-1521-9. Van der Willik EM, Meuleman Y, Prantl K, van Rijn G, Bos WJW, van Ittersum FJ, Bart HAJ, Hemmelder MH, Dekker FW. Patient-reported outcome measures: selection of a valid questionnaire for routine symptom assessment in patients with advanced chronic kidney disease – a four-phase mixed methods study. BMC Nephrology. 2019. Accepted. https://​doi.​org/​10.​1186/​s12882-019-1521-9.
43.
go back to reference Ware JE. SF-36 Health Survey. Manual and Interpretation Guide; 1997. Ware JE. SF-36 Health Survey. Manual and Interpretation Guide; 1997.
44.
go back to reference Wyld M, Morton RL, Hayen A, et al. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLOS. 2012;9(9):1–10. Wyld M, Morton RL, Hayen A, et al. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLOS. 2012;9(9):1–10.
45.
go back to reference Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: results from the IQOLA project. J Clin Epidemiol. 1998;51:1171–8.CrossRef Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: results from the IQOLA project. J Clin Epidemiol. 1998;51:1171–8.CrossRef
46.
go back to reference Loosman WL, Hoekstra T, van Dijk S, et al. Short-form 12 or short-form 36 to measure quality-of-life changes in dialysis patients? Nephrol Dial Transplant. 2015;30:1170–6.CrossRef Loosman WL, Hoekstra T, van Dijk S, et al. Short-form 12 or short-form 36 to measure quality-of-life changes in dialysis patients? Nephrol Dial Transplant. 2015;30:1170–6.CrossRef
47.
go back to reference World Health Organization. ICD-10. Internationale statistische classificatie van ziekten en met gezondheid verband houdende problemen, tiende revisie. 2014. World Health Organization. ICD-10. Internationale statistische classificatie van ziekten en met gezondheid verband houdende problemen, tiende revisie. 2014.
49.
go back to reference Bouwmans C, Krol M, Severens H, et al. The iMTA productivity cost questionnaire a standardized instrument for measuring and valuing health-related productivity losses. Value Health. 2015;18(6):753–8.CrossRef Bouwmans C, Krol M, Severens H, et al. The iMTA productivity cost questionnaire a standardized instrument for measuring and valuing health-related productivity losses. Value Health. 2015;18(6):753–8.CrossRef
50.
51.
go back to reference Hakkaart-van Roijen L, Van der Linden N, Bouwmans CAM, et al. Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg. Diemen: Zorginstituut Nederland; 2015. Hakkaart-van Roijen L, Van der Linden N, Bouwmans CAM, et al. Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg. Diemen: Zorginstituut Nederland; 2015.
52.
go back to reference Versteegh MM, Vermeulen KM, Evers SMAA, et al. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19:343–52.CrossRef Versteegh MM, Vermeulen KM, Evers SMAA, et al. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19:343–52.CrossRef
53.
go back to reference Brooks R, Group E. EuroQol: the current state of play. Health Policy. 1996;37:53–72.CrossRef Brooks R, Group E. EuroQol: the current state of play. Health Policy. 1996;37:53–72.CrossRef
54.
go back to reference Eikelenboom N, van Lieshout J, Wensing M, et al. Implementation of personalized self-management support using the self-management screening questionnaire SeMaS; a study protocol for a cluster randomized trial. Trials. 2013;14(336):1–9. Eikelenboom N, van Lieshout J, Wensing M, et al. Implementation of personalized self-management support using the self-management screening questionnaire SeMaS; a study protocol for a cluster randomized trial. Trials. 2013;14(336):1–9.
55.
go back to reference Eikelenboom N, Smeele I, Faber M, et al. Validation of self-management screening (SeMaS), a tool to facilitate personalised counselling and support of patients with chronic diseases. BMC Fam Pract. 2015;16(165):1–12. Eikelenboom N, Smeele I, Faber M, et al. Validation of self-management screening (SeMaS), a tool to facilitate personalised counselling and support of patients with chronic diseases. BMC Fam Pract. 2015;16(165):1–12.
56.
go back to reference Lan PG, Clayton PA, Johnson DW, et al. Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: proposal for a standardized definition of technique failure. Perit Dial Int. 2016;36:623–30.CrossRef Lan PG, Clayton PA, Johnson DW, et al. Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: proposal for a standardized definition of technique failure. Perit Dial Int. 2016;36:623–30.CrossRef
57.
go back to reference Hall YN, Larive B, Painter P, et al. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: frequent hemodialysis network (FHN) randomized trials. Clin J Am Soc Nephrol. 2012;7:782–94.CrossRef Hall YN, Larive B, Painter P, et al. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: frequent hemodialysis network (FHN) randomized trials. Clin J Am Soc Nephrol. 2012;7:782–94.CrossRef
58.
go back to reference Lowrie EG, Curtin RB, LePain N, et al. Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients. Am J Kidney Dis. 2003;41(6):1286–92.CrossRef Lowrie EG, Curtin RB, LePain N, et al. Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients. Am J Kidney Dis. 2003;41(6):1286–92.CrossRef
59.
go back to reference Korevaar JC, Jansen MAM, Merkus MP, et al. Quality of life in predialysis end-stage renal disease patients at the initiation of dialysis therapy. Perit Dial Int. 2000;20:69–75.PubMed Korevaar JC, Jansen MAM, Merkus MP, et al. Quality of life in predialysis end-stage renal disease patients at the initiation of dialysis therapy. Perit Dial Int. 2000;20:69–75.PubMed
60.
go back to reference Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095–108.CrossRef Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095–108.CrossRef
61.
go back to reference Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14:1523–32.CrossRef Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14:1523–32.CrossRef
62.
go back to reference Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life. JAMA. 2007;297(11):1291–9.CrossRef Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life. JAMA. 2007;297(11):1291–9.CrossRef
63.
go back to reference Jardine MJ, Gray NA, De Zoysa J, et al. Design and participant baseline characteristics of ‘a clinical trial of IntensiVE Dialysis': the ACTIVE Dialysis study. Nephrology. 2015;20:257–65.CrossRef Jardine MJ, Gray NA, De Zoysa J, et al. Design and participant baseline characteristics of ‘a clinical trial of IntensiVE Dialysis': the ACTIVE Dialysis study. Nephrology. 2015;20:257–65.CrossRef
64.
go back to reference Korevaar JC, Feith GW, Dekker FW, et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int. 2003;64:2222–8.CrossRef Korevaar JC, Feith GW, Dekker FW, et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int. 2003;64:2222–8.CrossRef
Metadata
Title
Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes (DOMESTICO): rationale and design
Authors
A. van Eck van der Sluijs
A. A. Bonenkamp
F. W. Dekker
A. C. Abrahams
B. C. van Jaarsveld
on behalf of the DOMESTICO study group
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1526-4

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.